SECOND SIGHT MED PRODS INC - COM (EYES)

CUSIP: 81362J100

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / COM
Total 13F shares
7,203,066
Share change
-189,250
Total reported value
$8,641,583
Price per share
$1.20
Number of holders
40
Value change
-$244,473
Number of buys
14
Number of sells
20

Quarterly Holders Quick Answers

What is CUSIP 81362J100?
CUSIP 81362J100 identifies EYES - SECOND SIGHT MED PRODS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SECOND SIGHT MED PRODS INC - COM (EYES) as of Q3 2017

As of 30 Sep 2017, SECOND SIGHT MED PRODS INC - COM (EYES) was held by 40 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,203,066 shares. The largest 10 holders included Versant Venture Management, LLC, VANGUARD GROUP INC, BlackRock Inc., VAN DEN BERG MANAGEMENT I, INC, MILLENNIUM MANAGEMENT LLC, Psagot Investment House Ltd., GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, Carl Domino Inc, and ORACLE INVESTMENT MANAGEMENT INC. This page lists 40 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.